Feitosa P, Castellano M, Costa C, Cardoso A, Pereira L, Fernandes F
J Bras Pneumol. 2024; 50(5):e20240235.
PMID: 39661838
PMC: 11601085.
DOI: 10.36416/1806-3756/e20240235.
Pierce L
Heliyon. 2024; 10(11):e31183.
PMID: 38912501
PMC: 11190464.
DOI: 10.1016/j.heliyon.2024.e31183.
Jardim J, Casas-Maldonado F, Fernandes F, Castellano M, Torres-Duran M, Miravitlles M
J Bras Pneumol. 2021; 47(3):e20200380.
PMID: 34076174
PMC: 8332724.
DOI: 10.36416/1806-3756/e20200380.
Tubio-Perez R, Torres-Duran M, Fernandez-Villar A, Ruano-Ravina A
Transl Oncol. 2020; 14(1):100914.
PMID: 33142121
PMC: 7642868.
DOI: 10.1016/j.tranon.2020.100914.
Evers G, Schulze A, Thrull M, Hering J, Schulke C, Wiewrodt R
Can Respir J. 2020; 2020:4019608.
PMID: 32566054
PMC: 7273390.
DOI: 10.1155/2020/4019608.
Images in COPD: Idiopathic Emphysema in a Never Smoker.
Leung S, Lee P, Most J, Sundaram B
Chronic Obstr Pulm Dis. 2020; 7(2):130-133.
PMID: 32324984
PMC: 7454019.
DOI: 10.15326/jcopdf.7.2.2020.0148.
Diagnosis and treatment of lung disease associated with alpha one-antitrypsin deficiency: A position statement from the Thoracic Society of Australia and New Zealand.
Dummer J, Dobler C, Holmes M, Chambers D, Yang I, Parkin L
Respirology. 2020; 25(3):321-335.
PMID: 32030868
PMC: 7078913.
DOI: 10.1111/resp.13774.
Exome Sequencing Reveals Immune Genes as Susceptibility Modifiers in Individuals with α-Antitrypsin Deficiency.
Rigobello C, Baraldo S, Tine M, Ferrarotti I, Corsico A, Bazzan E
Sci Rep. 2019; 9(1):13088.
PMID: 31511551
PMC: 6739380.
DOI: 10.1038/s41598-019-49409-1.
Alpha-1 antitrypsin deficiency as a common treatable mechanism in chronic respiratory disorders and for conditions different from pulmonary emphysema? A commentary on the new European Respiratory Society statement.
Gramegna A, Aliberti S, Confalonieri M, Corsico A, Richeldi L, Vancheri C
Multidiscip Respir Med. 2018; 13:39.
PMID: 30338069
PMC: 6174569.
DOI: 10.1186/s40248-018-0153-4.
Comparison of non-invasive assessment of liver fibrosis in patients with alpha1-antitrypsin deficiency using magnetic resonance elastography (MRE), acoustic radiation force impulse (ARFI) Quantification, and 2D-shear wave elastography (2D-SWE).
Reiter R, Wetzel M, Hamesch K, Strnad P, Asbach P, Haas M
PLoS One. 2018; 13(4):e0196486.
PMID: 29698472
PMC: 5919507.
DOI: 10.1371/journal.pone.0196486.
Alpha-1 Antitrypsin PiMZ Genotype Is Associated with Chronic Obstructive Pulmonary Disease in Two Racial Groups.
Foreman M, Wilson C, DeMeo D, Hersh C, Beaty T, Cho M
Ann Am Thorac Soc. 2017; 14(8):1280-1287.
PMID: 28380308
PMC: 5566271.
DOI: 10.1513/AnnalsATS.201611-838OC.
Global impact of bronchiectasis and cystic fibrosis.
Redondo M, Keyt H, Dhar R, Chalmers J
Breathe (Sheff). 2017; 12(3):222-235.
PMID: 28210295
PMC: 5298141.
DOI: 10.1183/20734735.007516.
Alpha-1 proteinase inhibitors for the treatment of alpha-1 antitrypsin deficiency: safety, tolerability, and patient outcomes.
Chotirmall S, Al-Alawi M, McEnery T, McElvaney N
Ther Clin Risk Manag. 2015; 11:143-51.
PMID: 25673994
PMC: 4321641.
DOI: 10.2147/TCRM.S51474.
Inflammatory cytokine response to exercise in alpha-1-antitrypsin deficient COPD patients 'on' or 'off' augmentation therapy.
Olfert I, Malek M, Eagan T, Wagner H, Wagner P
BMC Pulm Med. 2014; 14:106.
PMID: 24975928
PMC: 4091645.
DOI: 10.1186/1471-2466-14-106.
Validation and development of an immunonephelometric assay for the determination of alpha-1 antitrypsin levels in dried blood spots from patients with COPD.
Zillmer L, Russo R, Manzano B, Ivanaga I, Nascimento O, de Souza A
J Bras Pneumol. 2013; 39(5):547-54.
PMID: 24310627
PMC: 4075886.
DOI: 10.1590/S1806-37132013000500004.
Genes and chronic obstructive pulmonary disease.
Foreman M, Campos M, Celedon J
Med Clin North Am. 2012; 96(4):699-711.
PMID: 22793939
PMC: 3399759.
DOI: 10.1016/j.mcna.2012.02.006.
α1-Proteinase inhibitor (human) in the treatment of hereditary emphysema secondary to α1-antitrypsin deficiency: number and costs of years of life gained.
Sclar D, Evans M, Robison L, Skaer T
Clin Drug Investig. 2012; 32(5):353-60.
PMID: 22480280
DOI: 10.2165/11631920-000000000-00000.
Polymorphisms in the HPC/ELAC-2 and alpha 1-antitrypsin genes that correlate with human diseases in a North Indian population.
Sobti R, Thakur H, Gupta L, Janmeja A, Seth A, Singh S
Mol Biol Rep. 2010; 38(5):3137-44.
PMID: 20119870
DOI: 10.1007/s11033-010-9984-6.
Alpha-1-antitrypsin phenotypes in adult liver disease patients.
Topic A, Alempijevic T, Sokic Milutinovic A, Kovacevic N
Ups J Med Sci. 2009; 114(4):228-34.
PMID: 19961268
PMC: 2852779.
DOI: 10.3109/03009730903243472.
Chronic obstructive pulmonary disease: an update on diagnosis and management issues in older adults.
Nazir S, Erbland M
Drugs Aging. 2009; 26(10):813-31.
PMID: 19761275
DOI: 10.2165/11316760-000000000-00000.